DGAT1 and glioblastoma: Consistent with this hypothesis, combining inhibition of DGAT1, which has been shown to attenuate the formation of lipid droplets in GBM cells (35), enhanced the anti-tumor activity of the PUFA linoleic acid, supporting the concept that rational combinations designed to target lipid droplet homeostasis may enhance therapeutic response in GBM.